Terms: = Lung cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
1446 results:
1. SH003 Enhances the Anti-cancer Effects of Dabrafenib on lung cancer Harboring
Choi YJ; Chung YH; Lee K; Jeong M; Ko SG
Anticancer Res; 2024 May; 44(5):1905-1913. PubMed ID: 38677764
[TBL] [Abstract] [Full Text] [Related]
2. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/erk Signaling Pathway.
Zhang Y; Liu H; Liu X; Lang L
Discov Med; 2024 Apr; 36(183):836-841. PubMed ID: 38665031
[TBL] [Abstract] [Full Text] [Related]
3. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
Li Y; Sharma A; Hoffmann MJ; Skowasch D; Essler M; Weiher H; Schmidt-Wolf IGH
Front Immunol; 2024; 15():1268652. PubMed ID: 38558822
[TBL] [Abstract] [Full Text] [Related]
4. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target.
Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E
Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539
[TBL] [Abstract] [Full Text] [Related]
5. L-Methionine accentuates anti-tumor action of Gefitinib in Gefitinib-resistant lung adenocarcinoma: Role of EGFR/erk/AKT signaling and histone H3K36me2 alteration.
Pal S; Kabeer SW; Tikoo K
Toxicol Appl Pharmacol; 2024 Apr; 485():116907. PubMed ID: 38521369
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
7. TonEBP/NFAT5 expression is associated with cisplatin resistance and migration in macrophage-induced A549 cells.
Song HJ; Kim YH; Choi HN; Kim T; Kim SJ; Kang MW; Lee SD
BMC Mol Cell Biol; 2024 Mar; 25(1):6. PubMed ID: 38438872
[TBL] [Abstract] [Full Text] [Related]
8. Strophanthidin Induces Apoptosis of Human lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling.
Tian X; Gu L; Zeng F; Liu X; Zhou Y; Dou Y; Han J; Zhao Y; Zhang Y; Luo Q; Wang F
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398629
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
Chen J; Zheng Q; Wang J; Zhang X; Lv Y
Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
[TBL] [Abstract] [Full Text] [Related]
10. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
11. Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3.
Park WH
Ann Med; 2024 Dec; 56(1):2319853. PubMed ID: 38373208
[TBL] [Abstract] [Full Text] [Related]
12. The role of silymarin and MAPK pathway in the regulation of proliferation and invasion of non-small cell lung cancer cells.
Zhang J; Zhang K; Li J; Zhang J; Cui X
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):62-66. PubMed ID: 38372113
[TBL] [Abstract] [Full Text] [Related]
13. Targeting MEK in non-small cell lung cancer.
Lara MS; Blakely CM; Riess JW
Curr Probl Cancer; 2024 Apr; 49():101065. PubMed ID: 38341356
[TBL] [Abstract] [Full Text] [Related]
14. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
Gong B; Wang L; Zhang H; Wang Q; Li W
Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
[TBL] [Abstract] [Full Text] [Related]
15. Anticancer effect of zoledronic acid in endocrine-resistant breast cancer cells via HER-2 signaling.
Adchariyasakulchai P; Sakunrangsit N; Chokyakorn S; Suksanong C; Ketchart W
Biomed Pharmacother; 2024 Feb; 171():116142. PubMed ID: 38198953
[TBL] [Abstract] [Full Text] [Related]
16. Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer.
Zhang Y; Liu L; Pei J; Ren Z; Deng Y; Yu K
Oncogene; 2024 Feb; 43(9):668-681. PubMed ID: 38191673
[TBL] [Abstract] [Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis.
Liu S; Li X; Chen C; Lin X; Zuo W; Peng C; Jiang Q; Huang W; He G
Eur J Med Chem; 2024 Feb; 265():116100. PubMed ID: 38171149
[TBL] [Abstract] [Full Text] [Related]
18. Design, synthesis and antitumor activity of 4-arylamine substituted pyrimidine derivatives as noncovalent EGFR inhibitors overcoming C797S mutation.
Zuo Y; Long Z; Li R; Le Y; Zhang S; He H; Yan L
Eur J Med Chem; 2024 Feb; 265():116106. PubMed ID: 38169271
[TBL] [Abstract] [Full Text] [Related]
19. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/p38/MAPK signaling pathways.
Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of Polyinosinic-Polycytidylic Acid-Induced Acute Pulmonary Inflammation and NF-κB Activation in Mice by a Banana Plant Extract.
Liao CH; Lai TY; Lin YY; Liao YC; Lai GM; Chu TH; Wu SY; Tsai WL; Whang-Peng J; Liu F; Chiou TJ; Yao CJ
Int J Med Sci; 2024; 21(1):107-122. PubMed ID: 38164360
[TBL] [Abstract] [Full Text] [Related]
[Next]
